Company: SPRB
Filing Date: 2025-05-06
Form Type: 10-Q
Source: 0000950170-25-064463
Chunk: 8

Company: SPRUCE BIOSCIENCES, INC.
Filing Date: 2025-05-06
Form: 10-Q
Item: Item 6
Chunk 8
---
ExhibitNumber
      
     Description
      
     Form
      
     File No.
      
     Exhibit
      
     Filing Date

     3.1
      
     Amended and Restated Certificate of Incorporation
      
     8-K
      
     001-39594
      
     3.1
      
     October 14, 2020

     3.2
      
     Amended and Restated Bylaws 
      
     8-K
      
     001-39594
      
     3.2
      
     October 14, 2020

     4.1
      
     Form of 2025 Pre-Funded Warrant to Purchase Common Stock
      
     10-K
      
     001-39594 
      
     4.7
      
     April 15, 2025

     10.1*
      
     Collaboration and License Agreement, dated January 15, 2025, by and between Spruce Biosciences, Inc. and HBM Alpha Therapeutics, Inc.
      
     10-K
      
     001-39594
      
     10.28
      
     April 15, 2025

     31.1
      
     Certification of Principal Executive Officer pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
      
     Filed herewith

     31.2
      
     Certification of Principal Financial Officer pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
      
     Filed herewith

     32.1#
      
     Certification of Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
      
     Filed herewith

     32.2#
      
     Certification of Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of